Skip to content

News archive

  • ​A new principle for epigenetic changes

    In a new study, researchers at Uppsala University have found evidence of a new principle for how epigenetic changes can occur. The principle is based on an enzyme, tryptase, that has epigenetic effects that cause cells to proliferate in an uncontrolled manner.

  • Delayed clamping prevents anaemia

    When clamping of the umbilical cord is delayed, iron deficiency up to six months of age can be prevented, according to a new study from Uppsala University, published in JAMA Pediatrics. The study was conducted in Nepal.

  • New research study creates new opportunities for treating brain diseases

    Immunotherapy has proven to be effective against many serious diseases. But to treat diseases in the brain, the antibodies must first get past the obstacle of the blood-brain barrier. In a new study, a research group at Uppsala University describes their development of a new antibody design that increases brain uptake of antibodies almost 100-fold.

  • Inhibition of EZH2 might be new therapy of multiple myeloma

    In a study published in the scientific journal Oncotarget, researchers from Uppsala University show how the protein EZH2 affects the development of multiple myeloma, and that inhibition of EZH2 could be used as a new strategy to treat the disease. The tumour form multiple myeloma is today incurable and it has been challenging to improve therapy.

  • Researchers discover ‘Marvel microbes’ explaining how cells became complex

    In a new study published in Nature an international research group led from Uppsala University presents the discovery of a group of microbes that provide new insights as to how complex cellular life emerged. The study provides new details of how, billions of years ago, complex cell types that comprise plants, fungi, but also animals and humans, gradually evolved from simpler microbial ancestors.

  • Live cell imaging using a smartphone

    A recent study from Uppsala University shows how smartphones can be used to make movies of living cells, without the need for expensive equipment. The study is published in the open access journal PLOS ONE, making it possible for laboratories around the world to do the same thing.

  • Studies of one of the world’s rarest birds, the Rufous-headed Robin

    Researchers at the Chinese Academy of Sciences in Beijing and Uppsala University, Uppsala, Sweden have put together all known information about the endangered Rufous-headed Robin. Very few observations have been made since it was first discovered in 1905. The researchers suggest that its distribution might be larger than previously thought.

  • Therapy response in brain tumour cells is linked to disease prognosis

    The brain tumour form glioblastoma is difficult to treat and has very poor prognosis. In a new study, published today in the journal Cell Reports, scientists from Uppsala University show that a type of stem cell in the tumour is present in different states, with different response to drugs and radiation. The results may open an avenue towards development of new treatment strategies.

  • ​Collective dynamics in magnetic nano-structures

    Researchers at the Division of Solid-state Physics and the Division of Material Physics at Uppsala University have shown how the collective dynamics in a structure consisting of interacting magnetic nano-islands can be manipulated. Their findings are published in the scientific journal Scientific Reports

  • Localised immunotherapy new possibility to treat bladder cancer

    Antibody-based immunotherapy is a new promising method to treat cancer. Unfortunately, today’s treatments can result in adverse side effects. New findings from Uppsala University show an alternative way to administer the therapy, which has the same effect on the tumour but less impact other parts of the body.

  • One specific gene explains many diseases

    ​Genetic differences in the FADS1 gene and varying ability to produce polyunsaturated fats like omega-3 and omega-6 determine the risk for many different diseases, such as inflammatory diseases and several types of cancer. Scientists at Uppsala University/SciLifeLab in Sweden have clarified this in detail and the work is published in the journal Nucleic Acids Research.

Show more